Nuzenio

Definium Therapeutics Inc

Definium Therapeutics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Definium Therapeutics (DFTX) Is Up 6.0% After Strong DT120 Data Amid Wider Q2 Net Loss - simplywall.stsimplywall.st · Sat, 08 Aug 2026 23:35:37 GMT A Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $50 to $75 - MoomooMoomoo · Sat, 08 Aug 2026 17:29:18 GMT Definium Therapeutics, Inc. (NASDAQ:DFTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:43:13 GMT Definium Therapeutics (NASDAQ:DFTX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMT Definium Therapeutics (DFTX) Boosts Cash Reserves Amid Psychedelic Medicine Advances - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:29:32 GMT Is Definium Therapeutics Inc (DFTX) Facing Challenges After Repo - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:04:00 GMT Definium Therapeutics (DFTX) Reports Strong Phase III Data, Is It Still Below Fair Value? - SahmSahm · Fri, 07 Aug 2026 07:00:00 GMT Definium Therapeutics Inc (DFTX) (Q2 2026) Earnings Call Highlights: Record Phase III MDD ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:10:44 GMT

Timeline

Sat, 08 Aug 2026 23:35:37 GMTDefinium Therapeutics (DFTX) Is Up 6.0% After Strong DT120 Data Amid Wider Q2 Net Loss - simplywall.st

Sat, 08 Aug 2026 17:29:18 GMTA Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $50 to $75 - Moomoo

Sat, 08 Aug 2026 06:43:13 GMTDefinium Therapeutics, Inc. (NASDAQ:DFTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Sat, 08 Aug 2026 05:48:57 GMTDefinium Therapeutics (NASDAQ:DFTX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Fri, 07 Aug 2026 08:29:32 GMTDefinium Therapeutics (DFTX) Boosts Cash Reserves Amid Psychedelic Medicine Advances - GuruFocus

Fri, 07 Aug 2026 08:04:00 GMTIs Definium Therapeutics Inc (DFTX) Facing Challenges After Repo - GuruFocus

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

DFTX22 live mentions Definium Therapeutics14 live mentions NASDAQ6 live mentions Yahoo Finance Definium6 live mentions Financial Results6 live mentions Inc5 live mentions Yahoo Finance Yahoo5 live mentions Finance5 live mentions Earnings Call Highlights4 live mentions Therapeutics4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Definium Therapeutics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.